These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4082003)

  • 1. [Characteristics of the correction of the blood aggregate condition during extracorporeal hemosorption in hematologic patients].
    Katsadze IuL; Ganapiev AA
    Ter Arkh; 1985; 57(10):80-5. PubMed ID: 4082003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the adequacy of heparin administration during hemosorption].
    Iunovidova LI; Lekhtman AM; Levantovskaia OM
    Khirurgiia (Mosk); 1990 Jun; (6):85-8. PubMed ID: 2214584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Controlled heparinization during hemosorption].
    Marochkov AV; Iurchenko AA; Kravtsov NN
    Vestn Khir Im I I Grek; 1985 Mar; 134(3):101-3. PubMed ID: 4002508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complications of extracorporeal hemosorption and their prevention].
    Mazur LI; Nikolaĭchik VV; Astapenko VG; Ostapenko VA
    Vestn Khir Im I I Grek; 1983 Jun; 130(6):114-9. PubMed ID: 6612925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemosorption combined with intensive measures in hemoblastoses].
    Abdulkadyrov KM; Ganapiev AA
    Vopr Onkol; 1985; 31(6):43-8. PubMed ID: 3861025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The reaction to heparin in patients with burn toxemia during extracorporeal detoxification].
    Kholodov AIu; Val'dman BM; Lifshits RI; Puzhevskiĭ AS; Nalimov AG
    Klin Khir (1962); 1989; (3):37-9. PubMed ID: 2733362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of hemosorption on blood coagulation system factors in patients with severe suppurative infection].
    Shimkevich LL; Kostiuchenok BM; Rudneva VG; Chernov MI
    Vestn Khir Im I I Grek; 1986 Apr; 136(4):111-4. PubMed ID: 3750633
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in hemostatic system indices during hemosorption in healthy dogs].
    Glushkov VA; Vernigorova LA; Kosarenkov VA; Mosina ZM; Chertkov KS
    Biull Eksp Biol Med; 1982 Jul; 94(7):95-8. PubMed ID: 7126836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombocyte function in acute leukemia].
    Shitikova AS
    Arkh Patol; 1978; 40(9):85-91. PubMed ID: 708283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative detection and management of immune heparin-induced thrombocytopenia in patients undergoing heart surgery with iloprost.
    Palatianos GM; Foroulis CN; Vassili MI; Matsouka P; Astras GM; Kantidakis GH; Iliopoulou E; Melissari EN
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):548-54. PubMed ID: 14762367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiopulmonary bypass for patients with previously documented heparin-induced platelet aggregation.
    Olinger GN; Hussey CV; Olive JA; Malik MI
    J Thorac Cardiovasc Surg; 1984 May; 87(5):673-7. PubMed ID: 6717046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-dependent antibodies and thrombosis without heparin-induced thrombocytopenia.
    Bream-Rouwenhorst HR; Hobbs RA
    Pharmacotherapy; 2008 Nov; 28(11):1401-7. PubMed ID: 18957000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Our experience in the use of the hemosorption method in the combined therapy of patients with several forms of hemoblastoses].
    Nakhimov EI; Lebedev VN; Mochanov AS
    Gematol Transfuziol; 1983 Nov; 28(11):56-8. PubMed ID: 6689159
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostacyclin in lieu of anticoagulation with heparin for extracorporeal circulation.
    Addonizio VP; Fisher CA; Bowen JC; Palatianos GC; Colman RW; Edmunds LH
    Trans Am Soc Artif Intern Organs; 1981; 27():304-7. PubMed ID: 7036500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-like anticoagulant associated with multiple myeloma and neutralized with protamine sulfate.
    Torjemane L; Guermazi S; Ladeb S; Ben Romdhane N; Lakhal A; Abdelkefi A; Ben Othman T; Ben Abdelhadhim A
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):279-81. PubMed ID: 17413766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quantitative determination of heparin in the blood during hemosorption].
    Efimov VS
    Anesteziol Reanimatol; 1982; (6):46-9. PubMed ID: 7158844
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet involvement in the activated coagulation time of heparinized blood.
    Moorehead MT; Westengard JC; Bull BS
    Anesth Analg; 1984 Apr; 63(4):394-8. PubMed ID: 6367544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities.
    Fonseca RJ; Oliveira SN; Melo FR; Pereira MG; Benevides NM; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):539-45. PubMed ID: 18327402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo studies on the inhibition of coagulation by fractionated heparin and by a heparin analogue. I. Effects of heparin fractions.
    Schmitz-Huebner U; Balleisen L; Asbeck F; van de Loo J
    Thromb Haemost; 1981 Oct; 46(3):612-6. PubMed ID: 7031982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.